Udo Henseler, Director at RTI Biologics, Inc. (RTIX), bought 11,000 shares at $1.89 ($18K) on 2008-11-18, disclosed to the SEC on 2008-11-24.
Open-market purchase of $18k RTIX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.89 | 3,000 | $6K | 31.0% |
| 2 | $1.98 | 2,000 | $4K | 21.7% |
| 3 | $1.40 | 5,000 | $7K | 38.3% |
| 4 | $1.65 | 1,000 | $2K | 9.0% |
| Total | $1.66 avg | 11,000 | $18K | 100% |
| Filing → |
| RTIX | BUY | 2008-12-03 | $9K | — | Filing → |
| RTIX | SELL | 2008-08-20 | $40K | — | Filing → |
| RTIX | SELL | 2008-08-06 | $91K | — | Filing → |